drugset / Trial / NCT01797978
Methylene Blue in Severe Sepsis and Septic Shock
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is to see whether the intravenous administration of methylene blue improves the outcome in severe sepsis and septic shock.
Timeline
- Start
- 2013-02
- Primary completion
- 2016-01
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 0.5 mg/kg | Intravenous |